Staphylokinase (Sak) and Streptokinase (SK)
Staphylokinase (Sak) and Streptokinase (SK) are fascinating enzymes with a dual identity—used both in medicine and by bacteria as virulence factors. Medically, streptokinase (produced by Streptococcus pyogenes ) has long been used as a clot-dissolving drug in conditions like heart attacks, deep vein thrombosis, and pulmonary embolism. It is cost-effective but has notable drawbacks, including a high risk of systemic bleeding due to its non-specific action and the potential to trigger immune reactions, especially upon repeated use. In contrast, staphylokinase (from Staphylococcus aureus ) is still under clinical investigation but shows promise as a more clot-specific alternative, acting mainly at the site of clots and posing a lower bleeding risk. However, its clinical application is limited so far due to slower activation and ongoing trials. From a pathogenic standpoint, both enzymes help bac...